Emyria Ltd (EMD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.316x

Based on the latest financial reports, Emyria Ltd (EMD) has a cash flow conversion efficiency ratio of -0.316x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.67 Million ≈ $-1.18 Million USD) by net assets (AU$5.31 Million ≈ $3.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check asset allocation strategy of Emyria Ltd to assess the company's strategic physical and investment asset allocation.

Emyria Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Emyria Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Emyria Ltd net assets for net asset value and shareholders' equity analysis.

Emyria Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Emyria Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Femasys Inc
NASDAQ:FEMY
-0.706x
Sunrise New Energy Co. Ltd
NASDAQ:EPOW
-0.678x
Honey Badger Silver Inc
V:TUF
-0.508x
Skin n Skin Co. Ltd
KQ:159910
-0.211x
Despec Bilgisayar Pazarlama ve Ticaret AS
IS:DESPC
-1.667x
Saga Furs Oyj C
HE:SAGCV
-0.248x
Bull Will Co Ltd
TWO:6259
0.031x
Teaminvest Private Group Ltd
AU:TIP
0.063x

Annual Cash Flow Conversion Efficiency for Emyria Ltd (2018–2025)

The table below shows the annual cash flow conversion efficiency of Emyria Ltd from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see EMD stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$5.31 Million
≈ $3.75 Million
AU$-2.70 Million
≈ $-1.91 Million
-0.510x +71.14%
2024-06-30 AU$2.43 Million
≈ $1.72 Million
AU$-4.28 Million
≈ $-3.03 Million
-1.767x -218.22%
2023-06-30 AU$6.79 Million
≈ $4.81 Million
AU$-3.77 Million
≈ $-2.67 Million
-0.555x +35.34%
2022-06-30 AU$6.32 Million
≈ $4.47 Million
AU$-5.43 Million
≈ $-3.84 Million
-0.859x -56.53%
2021-06-30 AU$7.18 Million
≈ $5.08 Million
AU$-3.94 Million
≈ $-2.79 Million
-0.549x +53.40%
2020-06-30 AU$3.78 Million
≈ $2.68 Million
AU$-4.45 Million
≈ $-3.15 Million
-1.177x +77.33%
2019-06-30 AU$499.54K
≈ $353.46K
AU$-2.59 Million
≈ $-1.83 Million
-5.191x -69937.67%
2018-06-30 AU$2.81 Million
≈ $1.99 Million
AU$-20.82K
≈ $-14.73K
-0.007x --

About Emyria Ltd

AU:EMD Australia Health Information Services
Market Cap
$22.83 Million
AU$32.26 Million AUD
Market Cap Rank
#24716 Global
#1028 in Australia
Share Price
AU$0.04
Change (1 day)
-2.44%
52-Week Range
AU$0.02 - AU$0.07
All Time High
AU$0.50
About

Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-… Read more